Clicky

Johnson & Johnson(JNJ)

Description: Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers products used in the baby care, skin care, oral care, wound care, and women's health fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON'S, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, DABAO, VENDÔME, LISTERINE, REMBRANDT, REACH, BAND-AID, NEOSPORIN, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products directly, as well as through surgical supply and other distributors to wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.


Keywords: S&P 500 Pharmaceutical Products Pain Infectious Diseases Immunology Pharmacology Retail Outlets Skin Care Infection Pain Management Cardiovascular Disease Energy Products Hematology Diagnostic Products Urology Wound Insulin Lenses Glucose Gastrointestinal Neurology Dow Jones Component Contact Lens General Surgery Thrombosis Blood Glucose Monitoring Contact Lenses Infection Prevention Johnson & Johnson Antipsychotic Counter Pharmaceutical Products Infection Prevention Products Pseudoephedrine Aveeno Tylenol Insulin Delivery Splenda Urological Products

Home Page: www.jnj.com

JNJ Technical Analysis

One Johnson & Johnson Plaza
New Brunswick, NJ 08933
United States
Phone: 732 524 0400


Officers

Name Title
Mr. Alex Gorsky Exec. Chairman
Mr. Joaquin Duato CEO & Director
Mr. Joseph J. Wolk CPA Exec. VP & CFO
Ms. Jennifer L. Taubert Exec. VP & Worldwide Chairman of Pharmaceuticals
Mr. Robert J. Decker Jr. Controller & Chief Accounting Officer
Mr. James Swanson Exec. VP & Chief Information Officer
Ms. Jessica Moore VP of Investor Relations
Mr. Dirk Brinckman Chief Compliance Officer
Ms. Elizabeth Forminard Exec. VP & Gen. Counsel
Dr. Peter M. Fasolo Ph.D. Exec. VP & Chief HR Officer

Exchange: NYSE

Country: US

Currency: US Dollar ($)

Forward PE: 16.8919
Trailing PE: 23.9863
Price-to-Book MRQ: 6.1592
Price-to-Sales TTM: 4.8935
IPO Date: 1944-09-24
Fiscal Year End: December
Full Time Employees: 141700
Back to stocks